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Abstract. Nitric oxide (NO) is an endogenous free radical, which plays key roles in several 
biological processes including vasodilation, neurotransmission, inhibition of platelet adhesion, 
cytotoxicity against pathogens, wound healing, and defense against cancer. Due to the relative 
instability of NO in vivo (half-life of ca. 0.5 seconds), there is an increasing interest in the 
development of low molecular weight NO donors, such as S-nitrosothiols (RSNOs), which are 
able to prolong and preserve the biological activities of NO in vivo. In order to enhance the 
sustained NO release in several biomedical applications, RSNOs have been successfully allied 
to nanomaterials. In this context, this work describes the synthesis and characterization of the 
NO donor S-nitroso-mercaptosuccinic acid (S-nitroso-MSA), which belongs to the class of 
RSNOs, and its incorporation in polymeric biodegradable nanoparticles composed by 
alginate/chitosan. First, chitosan nanoparticles were obtained by gelation process with sodium 
tripolyphosphate (TPP), followed by the addition of the alginate layer, to enhance the 
nanoparticle protection. The obtained nanoparticles presented a hydrodynamic diameter of 343 
± 38 nm, polydispersity index (PDI) of 0.36 ± 0.1, and zeta potential of – 30.3 ± 0.4 mV, 
indicating their thermal stability in aqueous suspension. The negative zeta potential value was 
assigned to the presence of alginate chains on the surface of chitosan/TPP nanoparticles. The 
encapsulation efficiency of the NO donor into the polymeric nanoparticles was found to be 98 
± 0.2%. The high encapsulation efficiency value was attributed to the positive interactions 
between the NO donor and the polymeric content of the nanoparticles. Kinetics of NO release 
from the nanoparticles revealed a spontaneous and sustained release of therapeutic amounts of 
NO, for several hours under physiological temperature. The incubation of NO-releasing 
alginate/chitosan nanoparticles with human hepatocellular carcinoma (HepG2) cell line 
revealed a concentration-dependent toxicity. These results point to the promising uses of NO-
releasing alginate/chitosan nanoparticles for anti-cancer chemotherapy. 
1.  Introduction 
Polymeric nanoparticles composed by polysaccharides have been extensively studied due to their 
interesting properties such as biocompatibility and biodegradability [1]. Chitosan (CS) is on the most 
employed biopolymer in pharmacological and biomedical applications, in the forms of films, gels, 
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micro and nanoparticles [2]. Alginate (ALG) is naturally occurring polysaccharide extracted from 
brown seaweed. It is composed of two types of uronic acids, alfa-L-gluronic acid and beta-D-
manuronic acid, which contributes for the bioadhesiveness and drug-binding properties of this 
polymer [3]. ALG can interact with calcium inducing gel formation [4], and may also form complexes 
with polycations, CS or peptides [5]. 
 Nitric oxide (NO) is an important endogenous molecule, which plays several physiological and 
pathophysiological functions [1,6-8]. Among them, NO has toxicity towards cancer cells, depending 
on its concentration [9]. NO is a free radical and relatively instable in the biological medium. S-
nitrosothiols (RSNOs) are an important class of NO donors, acting as NO carriers able to spontaneous 
release free NO [10]. Recently, RSNOs have been incorporated into nanomaterials to enhance the 
sustained NO release in biomedical applications [1]. 
 The objective of this study was to describe the synthesis, characterization and cytotoxicity of CS 
nanoparticles containing the NO donor S-nitroso-mercaptosuccinic acid (S-nitroso-MSA), which 
belongs to the class of RSNOs [1,8]. ALG was added onto the surface of CS NPs, leading to the 
formation of S-nitroso-MSA-CS/ALG NPs (Figure 1).  
 
 
 
 
Figure 1. Schematic representation of the synthesized nanoparticles. ALG layer (grey circle) was 
added on the surface of CS NPs (black circle) containing the NO donor. 
 
 ALG is known to increase the mechanical properties of a biomaterial, and also to enhance the 
stability of encapsulated drugs decreasing the nanoparticle degradation in acid environment or 
minimizing the degradation actions of hydrolytic enzymes [11]. Moreover, both CS and ALG are 
mucoadhesive polymers, enhancing the delivery of therapeutic drugs to the mucus layers [12]. 
 In this study, polymeric nanoparticles made of CS and ALG were evaluated regarding their size, 
stability and potential as drug delivery system, further, the cytotoxicity of the NO-releasing polymeric 
nanoparticles was demonstrated towards human hepatocellular carcinoma (HepG2) cell line. The 
results suggest the potential uses of this nanomaterial against cancer cells.  
  
2.  Methods 
2.1.  Synthesis of MSA-CS/ALG NPs  
Firstly, CS NPs were synthesized by ionotropic gelation with sodium tripolyphosphate (TPP), as 
previous described [13]. Briefly, CS (2.6 mg·mL
-1
) and MSA (133.3 mmol·L
-1
) were mixed through 
magnetic stirring in an aqueous solution of acetic acid (0.175 mol·L
-1
) for 90 min. TPP aqueous 
solution (0.6 mg·mL
-1
) was added dropwise to the CS/MSA suspension, following the volumetric 
proportion of 3CS/MSA : 1TPP. The mixture was stirred for further 45 minutes at room temperature 
leading to the formation of aqueous suspension of CS NPs containing MSA, henceforth, referred as 
MSA-CS NPs. In a second step, the ALG layer was inserted onto the MSA-CS NPs, as previous 
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described [14]. Under magnetic stirring and at room temperature, ALG solution (1 mg·mL
-1
) was 
dropwise in the previous prepared MSA-CS NPs dispersion, following the volumetric proportion of 
1ALG: 1 MSA-CS NPs. The final mixture was stirred for further 30 min at room temperature forming 
a dispersion of MSA-CS/ALG NPs in which the MSA concentration is 50 mmol·L
-1
, showed in Figure 
1, and referred as MSA-CS/ALG NPs. 
 
2.2. Dynamic light scattering measurements (DLS)  
The hydrodynamic size diameter, polydispersity index (PDI), and zeta potential of MSA-CS/ALG NPs 
were evaluated by DLS (Nano ZS Zetasizer, Malvern Instruments Co, UK.) [15]. Measurements were 
performed at a fixed angle of 173°, using a disposable capillary cuvette (DTS1070) after a dilution of 
1:10. The results were reported as an average of three independent experiments with the error bar 
values expressed by their standard error of the mean (SEM). 
  
2.3. Encapsulation efficiency of MSA into CS/ALC NPs 
The encapsulation efficiency of MSA in CS/ALG NPs was measured by the titration of free thiols 
groups in the MSA structure with the thiol reagent 5,50-dithiobis-(2-nitrobenzoic acid) (DTNB),  
as already described [16]. Non-encapsulated (free) MSA was separated from encapsulated MSA by 
using a Microcon centrifugal filter device (MWCO 10,000, Millipore) and titrated with DTNB. The 
absorption band at 412 nm (Ɛ = 14.15 mmol-1Lcm-1), assigned to the formation of 2-nitro-5-
thiobenzoate anion that is generated in the reaction of DTNB with MSA, was measured in the ultra 
violet-visible spectrophotometer (Agilent 8453, Palo Alto, CA, USA). The analysis was performed in 
duplicates. The percentage of MSA encapsulation was determined by the described equation: 
 
(%) = (mass of MSA encapsulated/mass of MSA total) x 100   (Eq. 1) 
 
2.4. Nitrosation of MSA incorporated into CS/ALG NPs 
Free thiol group of MSA encapsulated into CS/ALG NPs was nitrosated by the addition of equimolar 
amount of sodium nitrite (NaNO2, 50 mmol·L
-1
) to the aqueous suspension of MSA-CS/ALG NPs (pH 
~4.0). The final suspension was stirred for 30 min in an ice bath (5°C), protected from the ambient 
light, leading to the formation of S-nitroso-MSA-CS/ALG NPs. The confirmation of the nitrosation of 
MSA yielding S-nitroso-MSA was performed by the appearance of the characteristic S-NO group 
absorption bands at 336 nm (ε = 980.0 mol-1·L·cm-¹) or at 545 nm (ε = 18.4 mol-1·L·cm-¹) by using the 
UV–vis spectrophotometer (Agilent 8453, Palo Alto, CA, USA).  
 
2.5. NO release profile from S-nitroso-MSA-CS/ALG NPs at physiological temperature 
The kinetics of NO release from S-nitroso-MSA-CS/ALG NPs was determined by monitoring the 
spectral changes at 545 nm (nN → π* transition) [15,17]. The decay of this absorption band is 
associated with the decomposition of S-nitroso-MSA with free NO release. The initial concentration of 
S-nitroso-MSA in the CS/ALG NPs was 50 mmol·L
-1 
and the kinetic data were collected in 30 min 
intervals at 37ºC for 6 h of monitoring. The amount of S-nitroso-MSA decomposed is related to the 
amount of NO released, since the decay of the absorption band at 545 nm over time is solely assigned 
to the cleavage of the S–N bond and NO release. Each point in the kinetic curves represents the 
average of two independent experiments, with the error bar values expressed by their standard error of 
the mean (SEM). In order to investigate the mechanism of NO release from S-nitroso-MSA-CS/ALG 
NPs, the Higuchi model was applied to kinetic curve [18-20]. According to the Higuchi model, the 
drug release is dependent of the square-root of time, as shown in Eq. 2, where QT is the amount of 
drug released at time t, KH is the Higuchi dissolution constant and t is time. The results were adjusted 
through linear regression and the correlation coefficient (R²) was analyzed [21]. 
 
Qt = KHt
-0.5
 (Eq. 2) 
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2.6. Cytotoxicity of S-nitroso-MSA-CS/ALG NPs 
The cytotoxicity of S-nitroso-MSA-CS/ALG NPs was evaluated towards human hepatocellular 
carcinoma (HepG2) cell line. Different concentrations of S-nitroso-MSA-CS/ALG NPs and MSA-
CS/ALG NPs (control group) were added to each well containing the cells followed by incubation for 
24 h at 37°C in a 5% CO2 atmosphere. After, 3-(4,5-dimethylthiazol-2-Yl)-2,5-diphenyltetrazolium 
bromide (MTT) solution (0.25 mg·mL
-1
) was added to each well followed by 4 h incubation. Then, 0.1 
mL of 10% SDS (prepared in 10 mmol·L
-1
 HCl) was added and incubated overnight to dissolve the 
formazan crystals, and the plates were read at 570 nm with 630 nm (BiochromAsys Expert Plus 
Microplate Reader, Biochrom Ltd., UK). The control was performed in the absence of NPs and 
considered as 100%. Each point represents the average of two independent experiments, with the error 
bar values expressed by their standard error of the mean (SEM).  
 
3.  Results and Discussion 
 
This main objective of this study was to obtain a polymeric NP able to carry and to deliver therapeutic 
amounts of NO for biomedical applications. To this end, this study reports the preparation of NO-
releasing CS based NPs, their characterization, the evaluation of the NO release profile from the NPs 
and the cytotoxicity of the NPs towards HepG2 cell line. The following sub-sections summarize the 
main results.  
3.1.  Synthesis and characterization of MSA-CS/ALG NPs 
Polymeric NPs based on CS and/or ALG have been broadly studied and employed as drug delivery 
system due to their unique chemical and biological properties, such as, mucoadhesiveness, 
biocompatibility, biodegradability, and non-toxicity [14,19,22]. Indeed, synthesis of CS NPs followed 
by the addition of ALG layer is able to promote sustained release of encapsulated drugs in a more 
efficacy manner in comparison with NPs comprised by only CS or ALG [22]. In this study, CS NPs 
were initially synthesized by the ionotropic gelation method, in which cationic chitosan chains readily 
interacts with the counter negatively charge TPP ions leading to the formation of the CS NP. This 
process is based on the interaction of cationic CS chains with multivalent counter ions resulting in the 
intermolecular and/or intramolecular network structure maintained by ionic interactions between NH3
+
 
protonated groups of CS and negatively charged counter ions of TPP. This cross linking leads to the 
formation of CS NPs. Encapsulation of MSA into CS NPs is performed by the strong electrostatic 
interactions between MSA and the CS chains. In a second step, addition ALG layers were added on 
the surface of MSA-CS NPs, leading to the formation of MSA-CS/ALG NPs. The presence of ALG is 
responsive to confer protection to MSA-CS NPs, which might decrease the degradation rates of NP in 
biological medium, and therefore protecting the NO donor.  
DLS measurements revealed that the hydrodynamic diameter of MSA-CS/ALG NPs was found to 
be 343 ± 38 nm with a moderate polydispersity index (PDI) of 0.36 ± 0.10. These results are in 
accordance Biswas and co-workers who reported a hydrodynamic diameter of 432 ± 52 nm and PDI 
value of 0.368 ± 0.06 for CS/ALG NPs containing antigens [14]. In addition, Costa and co-works 
reported the hydrodynamic diameter in the rage of 380-420 nm for CS/ALG NPs containing 
antibiotics [22].  
The zeta potential value for MSA-CS/ALG NPs was found to be -30.3 ± 0.4 mV, indicating a 
moderate stability of the NPs in aqueous environment, which is necessary for biomedical applications. 
The negative value of the zeta potential confirms the addition of ALG layers on the surface of MSA-
CS NPs, since ALG has negative charge due to the presence carboxyl groups. In contrast, a positive 
zeta potential value of 21.8 ± 1.1 mV was observed for MSA-CS NPs, prior the addition of ALG 
layers. This positive value is assigned to the presence of protonated amino groups found in CS chains. 
Our results are in accordance with published papers which report negative values for zeta potential of 
CS NPs coated with ALG layers, such as -16 to -26 mV for CS/ALG NPs containing paclitaxel [23], 
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and a zeta potential of ca. -38.2 ± 0.3 mV for antibiotic delivery, as reported by Costa and co-workers 
[22]. 
The encapsulation efficiency of MSA in CS/ALG NPs was found to be 98.05 ± 0.20 %, indicating 
a high affinity of MSA to the ALG/CS NPs, as previous described [16]. MSA has positive charge 
interactions with CS and ALG chains.  
 
3.2 Nitrosation of MSA-CS/ALG NPs leading to the formation of S-nitroso-MSA-CS/ALG NPs 
Free thiol groups of MSA-CS/ALG NPs were nitrosated by reacting by nitrous acid (HNO2) leading to 
the formation of S-nitroso-MSA-CS/ALG NPs, as shown in Figure 2A. HNO2 was generated by the 
presence of sodium nitrite (NaNO2) is acid solution. 
 
 
 
 
Figure 2. (A) Nitrosation of MSA forming the S-nitroso-MSA which acts as NO donor, (B) S-nitroso-
MSA decomposition releasing the free NO yielding oxidized MSA.  
 
3.3. NO release profile from S-nitroso-MSA-CS/ALG NPs at physiological temperature 
S-nitroso-MSA is a spontaneous NO donor as shown in Figure 2B. The kinetics of NO release from S-
nitroso-MSA-CS/ALG NPs in aqueous solution were monitored by following the spectral changes at 
545 nm absorption band, associated the S-N bound cleavage with free NO release (Figure 3) [15, 
16,19]. Figure 3 shows that the kinetic curve shows two distinct phases: an initial burst, in the first 2 h, 
of NO release with the dissolution constant (KH) of 39.05 ± 1.8 mmol·Lh
-0.5
, followed by a decrease in 
the rates of NO release from 2 to 6 h. Moreover, the concentration of NO release is in the mmol/L, at 
this concentration, NO is known to have antitumor and antibacterial activities [24-27]. The NO release 
from CS/ALG NPs is limited by several mechanisms, such as, diffusion, desorption, particle erosion or 
the combination of these factors. In order to evaluate the mechanism of NO release from the S-nitroso-
MSA-CS/ALG NPs, the Higuchi model was applied to the kinetic curve. The correlation coefficient 
(R
2
) obtained was of 0.981, which indicates that the main mechanism controlling the NO release is the 
diffusion process over the pores in the polymeric walls. Similar results were reported for the release of 
NO from CS/ALG NPs [19]. 
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Figure 3. Kinetics of NO release from S-nitroso-MSA-CS/ALG NPs (S-nitroso-MSA concentration of 
50 mmol∙L-1), at 37°C for 6 h. The results are presented as mean ± standard error of two independent 
experiments.  
 
 
3.4. Cytotoxicity of S-nitroso-MSA-CS/ALG NPs 
Figure 4 shows the viability of HepG2 cells upon treatment with S-nitroso-MSA-CS/ALG NPs and 
MSA-CS/ALG NPs. For both cases, a decrease in cell viability in a concentration-dependent manner 
was observed. At 40 µg·mL
-1
, viability of HepG2 cells decreased to 64.771 ± 7.928% upon incubation 
with S-nitroso-MSA-CS/ALG NPs. This decrease is ca. 22% lower compared to the cell viability upon 
HepG2 incubation with MSA-CS/ALG NPs at the same concentration.  
 
 
Figure 4. Viability of HepG2 tumor cells upon incubation with S-nitroso-MSA-CS/ALG NPs (empty 
squares) and MSA-CS/ALG NPs (black circles), at increasing concentrations. Cell viability was 
estimated by a tetrazolium-based (MTT) reduction assay. The results are presented in percentage of 
control (absence of NPs) as mean ± standard error of two independent experiments.  
 
It is noteworthy that the polymeric nanoparticle without NO also presented toxicity in HepG2 cells 
and this toxicity was further increased for the nanoparticle containing the NO donor. This result 
indicates that NO-releasing CS/ALG NPs presents potential to use against cancer cells.  
71234567890
Nanosafe  IOP Publishing
IOP Conf. Series: Journal of Physics: Conf. Series 838 (2017) 012032  doi :10.1088/1742-6596/838/1/012032
 
 
 
 
 
 
4.  Conclusions 
This work describes the synthesis and characterization of NO-releasing CS/ALG NPs. The NO donor 
S-nitroso-MSA was encapsulated into CS NPs, followed by the addition of ALG layer. This 
nanoparticle was able to spontaneously release free NO, following the Higuchi mathematical model. 
The cytotoxicity of S-nitroso-MSA CS/ALG NPs were demonstrated towards HepG2 tumor cell. 
Further studies to understand the molecular pathways involved in the cytotoxicity of this nanomaterial 
is under investigation.  
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